Physician profile
Ashwani Kumar
NPI 1134313216
$34,775.95
in general payments reported to CMS, 2019-2025
48 companies · $11K in 2025
The $11K reported for 2025 was more than what 89% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,719 · 2020: $369 · 2021: $17K · 2022: $1,035 · 2023: $1,120 · 2024: $1,407 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $7,637 · Food and Beverage: $5,782 · Education: $40.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $7,637.12 |
| Food and Beverage | $5,781.58 |
| Education | $40.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $23,973.09 | 2021-2025 | Corevalve Evolut R, Hawkone, Symplicity G3 |
| Abbott Laboratories | $3,675.04 | 2020-2025 | Xience V, Esprit, Pressurewire |
| Terumo Medical Corporation | $1,038.43 | 2019-2023 | Heartrail, Glidewire |
| Medtronic Vascular, INC. | $939.68 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $734.42 | 2019-2025 | |
| Pfizer INC. | $358.14 | 2019-2025 | |
| Cardiovascular Systems INC. | $316.90 | 2022-2023 | Diamondback Coronary |
| Boston Scientific Corporation | $309.90 | 2019-2025 | Watchman Flx |
| Amgen INC. | $266.81 | 2019-2024 | Repatha |
| Bayer Healthcare Pharmaceuticals INC. | $243.30 | 2020-2025 | |
| Bard Peripheral Vascular, INC. | $233.15 | 2019-2024 | Lutonix Drug Coated Balloon |
| Boehringer Ingelheim Pharmaceuticals, INC. | $228.86 | 2019-2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $226.62 | 2019-2024 | Xarelto |
| Abiomed | $207.34 | 2019-2025 | Impella |
| Novo Nordisk INC | $196.87 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $190.17 | 2019-2021 | |
| Cook Medical LLC | $169.07 | 2019-2025 | Zilver Ptx |
| Atricure, INC. | $161.99 | 2019-2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $130.51 | 2020-2025 | Lifevest |
| Sanofi-Aventis U.S. LLC | $125.27 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $104.13 | 2021-2024 | Eliquis, Camzyos |
| Penumbra, INC. | $76.82 | 2022-2025 | Penumbra System, Indigo System |
| Alnylam Pharmaceuticals INC. | $75.38 | 2022-2025 | Onpattro |
| Reflow Medical INC | $72.25 | 2025 | |
| Kiniksa Pharmaceuticals International, Plc | $49.41 | 2024 | Arcalyst |
| Astellas Pharma US INC | $47.05 | 2021 | |
| Esperion Therapeutics, INC. | $46.25 | 2020-2025 | Nexletol |
| Medicomp INC | $45.64 | 2022-2024 | Telepatch Cardiac Monitor |
| Chiesi USA, INC. | $43.21 | 2021-2023 | Kengreal |
| Edwards Lifesciences Corporation | $42.47 | 2023-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Bardy Diagnostics, INC. | $42.00 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $40.73 | 2021-2023 | Verquvo |
| Irhythm Technologies, INC. | $37.34 | 2019-2023 | Zio Xt Patch |
| Bridgebio Pharma, INC. | $31.98 | 2025 | Attruby |
| Glaxosmithkline, LLC. | $30.97 | 2025 | Ojjaara |
| Impulse Dynamics (USA) INC. | $28.97 | 2023 | Optimizer |
| Scpharmaceuticals INC. | $24.69 | 2023 | |
| Genzyme Corporation | $23.78 | 2023 | |
| Angiodynamics, INC. | $23.00 | 2019 | |
| Stryker Corporation | $21.72 | 2023 | N/A |
| Regeneron Healthcare Solutions, INC. | $21.40 | 2025 | Evkeeza |
| Azurity Pharmaceuticals, INC. | $20.94 | 2025 | Edarbyclor |
| Heartflow, INC. | $20.34 | 2025 | |
| Philips North America LLC | $18.13 | 2024 | (Ck4) Mcot |
| Lilly USA, LLC | $18.12 | 2025 | Zepbound |
| Lemaitre Vascular, INC. | $14.84 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $14.59 | 2024 | Opsumit, Uptravi |
| Kowa Pharmaceuticals America, INC. | $14.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashwani Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.